Sarabia, Naomi A.

HRN: 26-09-08  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/31/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/31/2024
11/07/2024
IV
4.5g
Q8
DM Foot
Waiting Final Action 

Indication:  Empirical Escalation    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: